Cargando…
One-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes
BACKGROUND: To compare wavefront (WF)-guided and WF-optimized laser in situ keratomileusis (LASIK) in hyperopes with respect to the parameters of safety, efficacy, predictability, refractive error, uncorrected distance visual acuity, corrected distance visual acuity, contrast sensitivity, and higher...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235493/ https://www.ncbi.nlm.nih.gov/pubmed/25419115 http://dx.doi.org/10.2147/OPTH.S70145 |
_version_ | 1782345036717883392 |
---|---|
author | Sáles, Christopher S Manche, Edward E |
author_facet | Sáles, Christopher S Manche, Edward E |
author_sort | Sáles, Christopher S |
collection | PubMed |
description | BACKGROUND: To compare wavefront (WF)-guided and WF-optimized laser in situ keratomileusis (LASIK) in hyperopes with respect to the parameters of safety, efficacy, predictability, refractive error, uncorrected distance visual acuity, corrected distance visual acuity, contrast sensitivity, and higher order aberrations. METHODS: Twenty-two eyes of eleven participants with hyperopia with or without astigmatism were prospectively randomized to receive WF-guided LASIK with the VISX CustomVue S4 IR or WF-optimized LASIK with the WaveLight Allegretto Eye-Q 400 Hz. LASIK flaps were created using the 150-kHz IntraLase iFS. Evaluations included measurement of uncorrected distance visual acuity, corrected distance visual acuity, <5% and <25% contrast sensitivity, and WF aberrometry. Patients also completed a questionnaire detailing symptoms on a quantitative grading scale. RESULTS: There were no statistically significant differences between the groups for any of the variables studied after 12 months of follow-up (all P>0.05). CONCLUSION: This comparative case series of 11 subjects with hyperopia showed that WF-guided and WF-optimized LASIK had similar clinical outcomes at 12 months. |
format | Online Article Text |
id | pubmed-4235493 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-42354932014-11-21 One-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes Sáles, Christopher S Manche, Edward E Clin Ophthalmol Original Research BACKGROUND: To compare wavefront (WF)-guided and WF-optimized laser in situ keratomileusis (LASIK) in hyperopes with respect to the parameters of safety, efficacy, predictability, refractive error, uncorrected distance visual acuity, corrected distance visual acuity, contrast sensitivity, and higher order aberrations. METHODS: Twenty-two eyes of eleven participants with hyperopia with or without astigmatism were prospectively randomized to receive WF-guided LASIK with the VISX CustomVue S4 IR or WF-optimized LASIK with the WaveLight Allegretto Eye-Q 400 Hz. LASIK flaps were created using the 150-kHz IntraLase iFS. Evaluations included measurement of uncorrected distance visual acuity, corrected distance visual acuity, <5% and <25% contrast sensitivity, and WF aberrometry. Patients also completed a questionnaire detailing symptoms on a quantitative grading scale. RESULTS: There were no statistically significant differences between the groups for any of the variables studied after 12 months of follow-up (all P>0.05). CONCLUSION: This comparative case series of 11 subjects with hyperopia showed that WF-guided and WF-optimized LASIK had similar clinical outcomes at 12 months. Dove Medical Press 2014-11-12 /pmc/articles/PMC4235493/ /pubmed/25419115 http://dx.doi.org/10.2147/OPTH.S70145 Text en © 2014 Sáles and Manche. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Sáles, Christopher S Manche, Edward E One-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes |
title | One-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes |
title_full | One-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes |
title_fullStr | One-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes |
title_full_unstemmed | One-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes |
title_short | One-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes |
title_sort | one-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235493/ https://www.ncbi.nlm.nih.gov/pubmed/25419115 http://dx.doi.org/10.2147/OPTH.S70145 |
work_keys_str_mv | AT saleschristophers oneyeareyetoeyecomparisonofwavefrontguidedversuswavefrontoptimizedlaserinsitukeratomileusisinhyperopes AT mancheedwarde oneyeareyetoeyecomparisonofwavefrontguidedversuswavefrontoptimizedlaserinsitukeratomileusisinhyperopes |